Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03878693 · ClinicalTrials.gov registry record · Early Phase 1
4-methylpyrazole and Acetaminophen Metabolism
A Early Phase 1 study of Healthy Adult Volunteers, sponsored by University of Arizona.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT03878693: Completed Early Phase 1 study of Healthy Adult Volunteers, sponsored by University of Arizona.
NCT03878693 is a Early Phase 1 study of Healthy Adult Volunteers that has completed, run by University of Arizona. The registered enrollment target is 6 participants, below the 22-participant average among 4 other Healthy Adult Volunteers trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03878693, a Early Phase 1 study of Healthy Adult Volunteers, has completed, sponsored by University of Arizona.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
Oxidative metabolism of APAP will be studied with and without 4-MP.
Primary Outcome
Measurement of oxidized metabolites of APAP
Conditions Studied
Interventions
- DRUG Fomepizole
- DRUG APAP
Study Locations (1)
Arizona
- BUMCP - Department of Medical Toxicology - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2018-07-01 |
| Est. Completion | 2018-10-31 |
| Phase | Early Phase 1 |
What the finished NCT03878693 record still lists
NCT03878693 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 22-participant average among 4 other Healthy Adult Volunteers trials with a reported enrollment target (73% lower).
The record links to 1 condition, with Healthy Adult Volunteers appearing as the primary indexed condition, and to 2 interventions - of which Fomepizole is the first listed.
NCT03878693 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT03878693 about?
NCT03878693 is a clinical study titled "4-methylpyrazole and Acetaminophen Metabolism". Oxidative metabolism of APAP will be studied with and without 4-MP.
What is the current status of trial NCT03878693?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 6 participants. The study started on 2018-07-01. Estimated completion is 2018-10-31.
What conditions does trial NCT03878693 study?
This clinical trial studies the following conditions: Healthy Adult Volunteers.
What interventions are being tested in trial NCT03878693?
The interventions under investigation include: Fomepizole (DRUG), APAP (DRUG).
Who is sponsoring clinical trial NCT03878693?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03878693 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Adult Volunteers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Drug Interaction Study of Multiple Doses of Isavuconazole and Single Dose of Dextromethorphan in Healthy Adult Subjects
COMPLETED · Phase 1
-
Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BMS-986120 in Healthy Subjects and the Effects of Co-Administration of Midazolam and BMS-986120
COMPLETED · Phase 1
-
A MAD Study of TT301/MW189 in Healthy Volunteers
COMPLETED · Phase 1
-
Assessment of End Expiratory Lung Volumes in Healthy Subjects Using High Flow Oxygen (Vapotherm®)
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI